NANOVALENT PHARMACEUTICALS INC
Advancing the Power of Targeted Therapies with nADCs
BOZEMAN, United States · Founded 2016 · $4.0M raised
- Headquarters
- BOZEMAN, Montana
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Website
- nanovalentpharma.com
- Total Funding
- $4.0M
- Last Round
- $4.0M Grant
- Rounds
- 1
About
NanoValent Pharmaceuticals develops novel nano-ADC-like Targeted Nanospheres (nADC/TNS) using a proprietary Hybrid Polymerized Liposomal Nanoparticle (HPLN) platform to deliver targeted cancer therapies with superior selectivity and reduced toxicity. Lead product NV103/NV105 is approaching IND status for glioblastoma, ovarian cancer, pancreatic cancer, and Ewing sarcoma.
Summary
NANOVALENT PHARMACEUTICALS INC is a Biotech company based in BOZEMAN, United States, founded in 2016. It has raised $4.0M in total across 1 round. Investors include National Institute of Health (NIH).
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Unknown
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...